Pulse Biosciences (PLSE) News Today → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free PLSE Stock Alerts $6.86 +0.01 (+0.15%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePulse Biosciences (NASDAQ:PLSE) Stock Crosses Below 50 Day Moving Average of $8.98americanbankingnews.com - April 13 at 5:00 AMQ4 2023 Pulse Biosciences Inc Earnings Callfinance.yahoo.com - March 29 at 10:48 AMPLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023investorplace.com - March 28 at 11:31 PMPulse Biosciences Inc (PLSE) Reports Increased GAAP Costs and Narrowed Net Loss in 2023finance.yahoo.com - March 28 at 7:45 PMPulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Resultsbusinesswire.com - March 28 at 4:12 PMPulse Biosciences Announces Plans to Initiate a Rights Offeringbusinesswire.com - March 28 at 4:10 PMPulse Biosciences (NASDAQ:PLSE) Stock Price Down 4.7%marketbeat.com - March 19 at 12:47 PMPLSE Apr 2024 25.000 callfinance.yahoo.com - March 17 at 10:01 AMPLSE Oct 2024 17.500 callfinance.yahoo.com - March 17 at 12:13 AMPLSE Oct 2024 12.500 callfinance.yahoo.com - March 16 at 2:13 PMPLSE Jul 2024 2.500 putfinance.yahoo.com - March 16 at 2:13 PMPulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024businesswire.com - March 14 at 4:05 PMPulse Biosciences’s CellFXnsPFA system secures FDA 510(k) clearancemsn.com - March 13 at 7:07 PMFDA clears Pulse Biosciences' soft tissue ablation systeminvesting.com - March 10 at 2:46 PMPulse Biosciences Gets FDA 510(k) Clearance For CellFX NsPFA Percutaneous Electrode Systemmarkets.businessinsider.com - March 9 at 1:21 AMPulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA(TM) Percutaneous Electrode Systemstockhouse.com - March 8 at 3:19 PMPulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode Systembusinesswire.com - March 8 at 1:17 PMPulse Biosciences (NASDAQ:PLSE) Shares Cross Below 50-Day Moving Average of $9.63marketbeat.com - February 16 at 5:28 AMPulse Biosciences Announces Positive Results For CellFX NsPFA 360 Cardiac Catheter Study; Stock Upmarkets.businessinsider.com - February 14 at 12:51 PMPulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Studyfinance.yahoo.com - February 14 at 12:51 PMPulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Studybusinesswire.com - February 14 at 8:00 AMPulse Biosciences (NASDAQ:PLSE) Share Price Passes Below Fifty Day Moving Average of $9.73marketbeat.com - February 8 at 6:58 AMCompanies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In Growthfinance.yahoo.com - February 2 at 12:21 PMPulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposiumfinance.yahoo.com - January 31 at 12:57 PMInsiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchasesfinance.yahoo.com - January 6 at 9:24 AMPulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clampfinance.yahoo.com - January 2 at 8:40 AMPulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheterfinance.yahoo.com - December 20 at 12:36 PMPulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases $843,504.48 in Stockmarketbeat.com - December 13 at 6:40 PMPulse Biosciences (NASDAQ:PLSE) Shares Up 8.9% After Insider Buying Activitymarketbeat.com - December 13 at 10:33 AMPulse Biosciences director Duggan buys shares worth $1.4M - filingmsn.com - December 5 at 7:33 PMExecutive Chairman of Pulse Biosciences Robert Duggan Buys More Stockfinance.yahoo.com - December 3 at 8:59 AMPulse Biosciences Up 16% on Product Updates, Potential Stock Purchases by Dugganmarketwatch.com - November 27 at 5:42 PMPulse Biosciences as chairman cleared to buy up to 1M stockmsn.com - November 27 at 5:42 PMPulse Biosciences: Cash Flow Bleed Remains A Concern Ahead Of 2024 Catalystsseekingalpha.com - November 21 at 6:05 PMPulse Biosciences Files 510(k) Submission With FDA For Its CellFX NsPFAmarkets.businessinsider.com - November 21 at 12:48 PMPulse Biosciences Shares Climb On Application for Percutaneous Electrode Reviewmarketwatch.com - November 21 at 12:48 PMPulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrodefinance.yahoo.com - November 21 at 12:48 PMChief Strategy Officer of Pulse Biosciences Picks Up 24% More Stockfinance.yahoo.com - November 18 at 10:03 AMPulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 15 at 5:42 PMPulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 4:41 PMQ3 2023 Pulse Biosciences Inc Earnings Callfinance.yahoo.com - November 14 at 8:23 AMPulse Biosciences Inc (PLSE) Reports Decrease in Q3 Losses and Advances in Cardiac Device ...finance.yahoo.com - November 13 at 3:16 PMPulse Biosciences GAAP EPS of -$0.19msn.com - November 13 at 10:16 AMPulse Biosciences, Inc. (PLSE) Q3 Loss Dropsmarkets.businessinsider.com - November 13 at 10:16 AMPulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 10:16 AMUPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Callfinance.yahoo.com - November 10 at 7:03 PMOrlando City Council approves purchase of Pulse sitebizjournals.com - October 30 at 11:44 PMPulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023finance.yahoo.com - October 30 at 6:44 PMPulse Shootingabcnews.go.com - October 27 at 6:53 AMPulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgeryfinance.yahoo.com - October 24 at 9:55 AM Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him PLSE Media Mentions By Week PLSE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLSE News Sentiment▼0.000.46▲Average Medical News Sentiment PLSE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLSE Articles This Week▼01▲PLSE Articles Average Week Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SKIN News Today OSUR News Today NVRO News Today ANIK News Today SRDX News Today NPCE News Today BVS News Today OFIX News Today CVRX News Today TCMD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLSE) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
